GreenLight Biosciences Holdings
GreenLight Biosciences Holdings (GRNA) Revenue
Annual & quarterly revenue history · segment & region breakdown
GRNA · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsGreenLight Biosciences Holdings trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
BiotechnologyCompare GRNA revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income GreenLight Biosciences Holdings receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
GreenLight Biosciences Holdings reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from GreenLight Biosciences Holdings's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GRNA revenue · 4 questionsGRNA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · GreenLight Biosciences Holdings SEC filings · GAAP · GreenLight Biosciences Holdings SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026